Loading insider details...
Beta
Latest Form 4 (Sep 24, 2026): Sale of 27,612 SKYE shares, $45.6K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 24, 2026 | Skye Bioscience, Inc. (SKYE) | Sale | 27,612 | $45.6K |
| Sep 18, 2026 | Skye Bioscience, Inc. (SKYE) | Sale | 32,607 | $62.3K |
| Aug 20, 2026 | Skye Bioscience, Inc. (SKYE) | Sale | 45,090 | $17.1K |
| Aug 5, 2026 | Camp4 Therapeutics Corp (CAMP) | Purchase | 3,179,558 | $4.86M |
| Sep 16, 2025 | Camp4 Therapeutics Corp (CAMP) | Purchase | 2,941,176 | $4.50M |
| Aug 22, 2025 | Skye Bioscience, Inc. (SKYE) | Sale | 58,642 | $209.4K |
| Sep 13, 2024 | Skye Bioscience, Inc. (SKYE) | Sale | 214,556 | $1.42M |
| Mar 15, 2024 | Skye Bioscience, Inc. (SKYE) | Purchase | 450,000 | $4.50M |
| Feb 2, 2024 | Skye Bioscience, Inc. (SKYE) | Purchase | 5,206,074 | $12.03M |